MXi Pharmaceuticals has recieved approval to begin a trial for ovarian/uterine cancer. The company hopes to start enrolling patients this calendar year.
See the news release here
Enroll in clinical trials here
- Just Diagnosed?
- About Ovarian Cancer
- Resources
- Advocacy
- Get Involved
